← Open Payments lookup

SCOTT SPRINGER: Open Payments

NPI 1154075018 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,699 in 95 payments from 9 companies in 2025. Trend: 2023 $38,428 · 2024 $30,846 · 2025 $21,699

Speaker / faculty: $9,185Consulting: $6,013Travel & lodging: $3,789Food & beverage: $2,712
CompanyPaymentsAmount
ABBVIE INC.28$11,032
Gilead Sciences, Inc.29$6,411
Ipsen Biopharmaceuticals, Inc9$2,440
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$1,052
Novo Nordisk Inc4$273
GlaxoSmithKline, LLC.1$250
Madrigal Pharmaceuticals9$202
Intercept Pharmaceuticals, Inc.1$24
Orexo US, Inc.1$16

Products named: MAVYRET, Epclusa, IQIRVO, XIFAXAN, REZDIFFRA, Biktarvy, Wegovy, UBRELVY.

Industry payments across NY — which companies pay providers there.